Table 4 Type of anti-malarials used by source among individuals who reported having fever in last two weeks and who were treated for malaria (N = 875).
| Â | Anti-malarial type | ||||
|---|---|---|---|---|---|
|  | AS+SP (n = 382) | SP or Chloroquine (n = 122) | Quinine (n = 39) | Artemether (n = 296) | Other†(n = 36) |
Overall | 43.9 (39.6-48.2) | 13.4 (10.6-16.2) | 4.5 (2.8-6.1) | 33.7 (30.0-37.4) | 4.6(2.7-6.5) |
By treatment source | Â | Â | Â | Â | Â |
Government | Â | Â | Â | Â | Â |
Hospital | 29.0 (21.2-36.8) | 20.3 (11.3-29.3) | 50.2 (27.8-72.6) | 28.4 (21.4-35.3) | 21.4 (7.6-35.1) |
Health centre | 36.5 (27.3-45.7) | 24.0 (14.7-33.2) | 33.6 (11.1-56.1) | 35.8 (29.2-42.4) | 20.2 (4.7-35.8) |
Basic health unit | 10.5 (4.9-16.0) | 14.6 (6.6-22.7) | 5.4 (-0.0-11.1) | 13.7 (7.6-19.7) | Â |
Community Health Worker | 7.0 (2.1-11.8) | 5.8 (0.7-11.0) | 7.2 (-0.2-14.6) | 4.4 (1.7-7.2) | 5.5 (-5.0-15.9) |
Private | Â | Â | Â | Â | Â |
Health facility/pharmacy/drug Store | 14.6 (9.3-20.0) | 20.0 (10.9-29.1) | 2.1 (-1.9-6.2) | 14.7 (10.3-19.1) | 40.2 (18.3-62.1) |
Shop | 1.6 (0.3-28.6) | 15.2 (7.3-23.2) | 1.4 (-1.4-4.2) | 1.1 (-0.6-2.9) | 12.7 (-4.3-29.9) |
Other | 0.7 (-0.0-1.7) | Â | Â | 1.8 (-0.0-3.8) | Â |